Validity of Wearable Sensor for Jump Height (Jump)

December 14, 2025 updated by: Busra Kalkan Balak

Evaluatıon of the Valıdıty of a Wearable Motıon Analysıs Sensor in Assessıng Jump Heıght

This study aims to evaluate the concurrent validity of a wearable motion sensor (BTS G-sensor) in measuring countermovement jump (CMJ) height. Healthy female volunteers between 18 and 35 years of age will perform CMJ tests. Jump height will be measured simultaneously using the BTS G-sensor and the My Jump smartphone application, which has previously demonstrated validity and reliability. The study will assess the level of agreement between the two measurement methods.

Study Overview

Detailed Description

Vertical jump height is widely used as an indicator of lower limb strength and functional performance. Force platforms are the gold standard for jump height measurement but are expensive and not always practical. Wearable motion sensors and smartphone applications have been developed as low-cost and portable alternatives.

This observational study is designed to examine the concurrent validity of the BTS G-sensor, a wearable inertial measurement unit, for measuring countermovement jump (CMJ) height. Measurements obtained from the BTS G-sensor will be compared with those from the My Jump smartphone application, a validated reference tool.

Healthy female volunteers aged 18-35 years will perform countermovement jumps after a standardized warm-up. Each participant's jump height will be simultaneously recorded by both methods. Data will be analyzed using correlation and agreement analyses to determine the level of consistency between the two methods.

This is an observational validation study. Both the BTS G-sensor and the My Jump application were used simultaneously for measurement purposes only. No interventional procedure or assignment was applied to participants.

Clarification on Study Type:

This is an observational validation study. Both the BTS G-sensor and the My Jump smartphone application were used simultaneously for measurement purposes only. No participant assignment or interventional procedure was applied.

Study Type

Observational

Enrollment (Actual)

29

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy female volunteers between the ages of 18 and 35 years were recruited from Ankara Yildirim Beyazıt University. Participants had no recent orthopedic injuries, no neurological conditions, and were not using medications that could affect balance.

Description

  • Inclusion Criteria:Female volunteers aged 18-35 years
  • No history of orthopedic injury in the past 6 months
  • No neurological disorders
  • Not taking medications affecting balance
  • Exclusion Criteria: Body Mass Index (BMI) > 25
  • History of orthopedic surgery
  • Impaired lower extremity joint range of motion
  • Inability to complete the test protocol
  • Measurement errors or missing data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Volunteers
Healthy female participants aged 18-35 years performed countermovement jumps. Jump height was measured simultaneously using the BTS G-sensor and the My Jump application.
A wearable motion analysis sensor used to assess countermovement jump height.
Other Names:
  • my jump lab
A wearable inertial measurement unit (IMU) used to assess countermovement jump (CMJ) height.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jump Height Measured with BTS G-sensor Compared to My Jump Application
Time Frame: single testing session, Day 1
Countermovement jump (CMJ) height measured simultaneously with the BTS G-sensor and the My Jump smartphone application. Agreement between the two methods will be analyzed using correlation and Bland-Altman plots.
single testing session, Day 1
Jump Height measured with BTS G-sensor compared to My Jump application
Time Frame: single testing session, Day 1
The countermovement jump (CMJ) height will be measured simultaneously using the BTS G-sensor and the My Jump smartphone application. Correlation and agreement between the two methods will be assessed.
single testing session, Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

September 29, 2025

First Submitted That Met QC Criteria

December 14, 2025

First Posted (Actual)

December 29, 2025

Study Record Updates

Last Update Posted (Actual)

December 29, 2025

Last Update Submitted That Met QC Criteria

December 14, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • AnkaraYBU-02-1155
  • 02-1155 (Other Identifier: Ankara Yıldırım Beyazıt University Faculty of Health Sciences Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

It is not yet determined whether individual participant data (IPD) will be shared. Decisions will depend on future institutional policies and publication requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on BTS G-sensor

Subscribe